Loading…
Novavax, Inc. is projected to rise to $8.51 by 2027, a +16% move from its current price of $7.32. NVAX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $7.14 | $7.32 | $7.50 | +0.01% |
| Aug 3 | $7.07 | $7.32 | $7.58 | +0.02% |
| Aug 4 | $7.02 | $7.32 | $7.64 | +0.03% |
| Aug 5 | $6.97 | $7.32 | $7.69 | +0.03% |
| Aug 6 | $6.93 | $7.32 | $7.74 | +0.04% |
| Aug 7 | $6.90 | $7.32 | $7.78 | +0.05% |
| Aug 8 | $6.86 | $7.32 | $7.82 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.86 | $7.32 | $7.82 | +0.06% |
| Week 2 | $6.69 | $7.33 | $8.03 | +0.12% |
| Week 3 | $6.55 | $7.33 | $8.21 | +0.18% |
| Week 4 | $6.44 | $7.34 | $8.35 | +0.24% |
| Week 5 | $6.35 | $7.34 | $8.49 | +0.30% |
| Week 6 | $6.27 | $7.35 | $8.61 | +0.37% |
| Week 7 | $6.19 | $7.35 | $8.73 | +0.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Novavax, Inc. is a biotechnology company that engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.
Novavax commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine.
The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. (NVAX) is a biotechnology company in the Healthcare sector.
The asset is currently trading at $7.83.
Its market cap is $1.29B and its rank is 2314.
The overall price outlook is shown by the year-by-year forecast, with the average price rising from $7.83 in 2026 to $12.82 in 2030 and to $44.97 in 2050, signaling upside potential over the longer term.
A major floor 22.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 33.1% above — a clean break opens room to run.
A major ceiling 51.5% above — clearing it would confirm fresh momentum.
Key NVAX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVAX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.39 | Sell | $7.43 | Sell |
| MA 10 | $7.61 | Sell | $7.66 | Sell |
| MA 20 | $8.26 | Sell | $8.06 | Sell |
| MA 50 | $8.98 | Sell | $8.59 | Sell |
| MA 100 | $8.94 | Sell | $8.73 | Sell |
| MA 200 | $8.47 | Sell | $8.61 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 29.95 | Buy |
| Stoch RSI (14) | 12.96 | Buy |
| CCI (20) | -95.60 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -13.17 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.66 | Sell |
| Awesome (5,34) | -1.24 | Sell |
| Ultimate (7,14,28) | 17.78 | Buy |
| Momentum (10) | -0.89 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 7.26 | Buy |
| ADX (14) | 25.83 | Sell |
| ATR (14) | 0.18 | Info |
Sentiment is NEUTRAL in the near term. RSI14 is 30. The 50-day simple moving average is $9.20 and the 200-day simple moving average is $8.51. The nearest support is $7.83 and the resistance is $9.74.
The 30-day price range is $6.54 to $9.36.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.13 | $7.32 | $9.23 | 0% | Neutral | |
| $6.85 | $8.51 | $11.13 | +16% | Neutral | |
| $7.15 | $9.10 | $12.33 | +24% | Bullish | |
| $8.03 | $10.44 | $14.52 | +43% | Bullish | |
| $8.65 | $11.46 | $16.31 | +57% | Bullish | |
| $8.16 | $10.98 | $15.93 | +50% | Bullish | |
| $8.44 | $11.54 | $17.05 | +58% | Bullish | |
| $8.59 | $11.92 | $17.89 | +63% | Bullish | |
| $8.93 | $12.55 | $19.12 | +72% | Bullish | |
| $10.78 | $15.36 | $23.71 | +110% | Bullish | |
| $11.87 | $17.92 | $29.29 | +145% | Bullish | |
| $22.85 | $38.10 | $67.73 | +420% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.13 | $7.32 | $8.68 | +0.00% |
| September 2026 | $6.29 | $7.43 | $8.99 | +1.43% |
| October 2026 | $6.22 | $7.38 | $9.02 | -0.63% |
| November 2026 | $6.09 | $7.26 | $8.94 | -1.61% |
| December 2026 | $6.21 | $7.44 | $9.23 | +2.49% |
Click any year to see its month-by-month NVAX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NVAX is projected to trade between $7.13 and $9.23, averaging $7.32 — a potential gain of 0% from today's $7.32. Price action looks broadly range-bound.
Novavax, Inc.'s 2027 outlook centres on $8.51, within a $6.85 to $11.13 range. That is up +16% on the projected 2026 average. That marks a +16% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, NVAX could reach as high as $12.33, with a base case around $9.10 and support toward $7.15 — roughly +24% from $7.32. Momentum favours further upside here.
Expect NVAX to range from $8.03 to $14.52 through 2029. The $10.44 average target implies a +43% move from current prices. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NVAX price prediction for 2030 points to an average of $11.46 (low $8.65, high $16.31) — a potential gain of +57% on today's $7.32. Momentum favours further upside here.
In 2031, NVAX is projected to trade between $8.16 and $15.93, averaging $10.98 — a potential gain of +50% from today's $7.32. That is -4% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Novavax, Inc.'s 2032 outlook centres on $11.54, within a $8.44 to $17.05 range. That is up +5% on the projected 2031 average. That marks a +58% change versus current levels. Momentum favours further upside here.
By 2033, NVAX could reach as high as $17.89, with a base case around $11.92 and support toward $8.59 — roughly +63% from $7.32. Buyers look set to stay in control over this stretch.
Expect NVAX to range from $8.93 to $19.12 through 2034. The $12.55 average target implies a +72% move from current prices. That is up +5% on the projected 2033 average. Momentum favours further upside here.
The NVAX price prediction for 2035 points to an average of $15.36 (low $10.78, high $23.71) — a potential gain of +110% on today's $7.32. Buyers look set to stay in control over this stretch.
In 2040, NVAX is projected to trade between $11.87 and $29.29, averaging $17.92 — a potential gain of +145% from today's $7.32. That is up +17% on the projected 2035 average. Momentum favours further upside here.
Novavax, Inc.'s 2050 outlook centres on $38.10, within a $22.85 to $67.73 range. That is up +113% on the projected 2040 average. That marks a +420% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVAX today (≈ 136.612022 NVAX) could be worth
$5,204.48
+$4,204.48 (+420%) by 2050 · US Dollar
Based on the average projected NVAX price of $38.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVAXwould be worth at today's price.
$1,000 invested in NVAX on Jul 31, 2025 (≈ 150.375938 NVAX) would be worth
$1,100.75
+$100.75 (+10.1%) today · 1.10× · US Dollar
Based on a NVAX entry price of $6.65 vs. today's $7.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.46 | $981.23 | -1.9% |
| 1 month ago | $9.46 | $773.78 | -22.6% |
| 3 months ago | $8.04 | $910.45 | -9.0% |
| 6 months ago | $8.69 | $842.35 | -15.8% |
| 1 year ago | $6.65 | $1,100.75 | +10.1% |
| All time (5.0y) ago | $182.72 | $40.06 | -96.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVAX forecast.
Our base-case forecast reaches $15.00 around 2035.
Implied market cap at $15.00: $2.47B
The multi-year forecast shows a rising trajectory. The 2026 average is $7.83 and the 2030 average is $12.82 with a 63.8% ROI and a BULLISH sentiment.
From 2031 to 2035, the forecast averages are $12.19, $12.96, $13.34, $14.21, and $17.81 respectively, with ROIs of 55.8%, 65.6%, 70.4%, 81.6%, and 127.6% and a generally BULLISH outlook.
By 2040 the average is $20.35 with a 160% ROI, and by 2050 the average is $44.97 with a 474.7% ROI, both with a BULLISH sentiment. These are estimates and not guarantees; actual results may vary.
Tap a question to reveal the answer.
The forecast lists an average price of $12.82 in 2030 with a ROI of 63.8%.
Forecasts show NEUTRAL in 2026 and BULLISH from 2028 onward, with the average price rising to $20.35 by 2040 and $44.97 by 2050.
The 2040 average price is $20.35 and the 2040 max is $34.33.
Current price is $7.83; market cap is $1.29B.
The thirty-day range is $6.54 to $9.36.
Novavax, Inc. Community Discussion
0Share your Novavax, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.